ManagedCareCGM.com Presents: Improving Quality Metrics and Reducing Cost of Care with Access to Real-Time Continuous Glucose Monitoring

Intended Audience: This activity is designed to meet the educational needs of managed care pharmacy directors, clinical pharmacists, quality directors, medical directors, registered nurses, and other managed health care professionals.

Credit Available: Up to 1.0 credit hour available for nurses (ANCC), pharmacists (ACPE), and physicians (AMA PRA Category 1 Credit™)

EDUCATIONAL OBJECTIVES

• Characterize the value of health technology and remote patient monitoring as part of a comprehensive management strategy for diabetes to improve glycemic outcomes
• Discuss the positive impact of pharmacy coverage on payer management interventions, provider administrative burden, member experience and access, and overall cost of care
• Review the potential of rtCGM to improve diabetes performance measures via hypoglycemia risk reduction, improved HbA1c, and reduced resource utilization with case scenarios (e.g., pregnancy; senior populations)

EXPERT FACULTY

Jeffrey Dunn, PharmD, MBA Head of Clinical Pharmacy Berkshire Hathaway/Geico (formerly Haven, the Amazon, Berkshire Hathaway, JPMorgan Chase healthcare venture) Formerly VP, Clinical Strategy and Programs and Industry Relations Magellan Rx Management	Maria Lopes, MD, MS Former Chief Medical Officer Magellan Health
Janet B. McGill, MD, MA, FACE, FACP Professor of Medicine Washington University School of Medicine	Vanita Pindolia, PharmD, BCPS, MBA Formerly Vice President, Ambulatory Clinical Pharmacy Programs_PCM Henry Ford Health System/Health Alliance Plan of Michigan

Jointly provided by Impact Education, LLC, and Medical Education Resources.
This activity is supported by an independent educational grant from Dexcom, Inc.

---

Best Practices in Continuous Glucose Monitoring in the Inpatient Setting during the COVID-19 Pandemic

Intended Audience: This activity was planned to meet the educational needs of pharmacists who practice in hospitals and health systems.

Credit Available: Up to 1.0 hour

LEARNING OBJECTIVES

At the conclusion of this activity, participants should be able to:

• Identify which hospitalized patients with diabetes and COVID-19 infections are candidates for CGM systems.
• Discuss the benefits of the use of CGMs in hospitals during the COVID-19 pandemic on healthcare personnel and patients.
• Summarize the role of the pharmacist in employing continuous glucose monitoring systems in appropriate hospitalized patients. 

EXPERT FACULTY

Matt Baker, Pharm.D., M.S., BCPS, BPLA, Activity Chair
Pharmacy Clinical Supervisor
Pharmacy Residency Program Director
North Kansas City Hospital
North Kansas City, Missouri

Guillermo E. Umpierrez, M.D., CDCES, MACP, FACE
Professor of Medicine, Emory University School of Medicine
Division of Endocrinology and Metabolism
Chief of Diabetes and Endocrinology, Grady Health Systems
Atlanta, Georgia

This activity is supported by an educational grant from Dexcom, Inc.

---

CGM Virtual Crossfire Series

Part 2: Incorporating Real-Time – Integrated CGM: Opportunities in the Pharmacy to Improve Quality of Life for Patients With Diabetes (Pharmacist Credit)

Intended Audience: Health-system, managed care, retail, and specialty pharmacists, and pharmacy technicians

Credit Available: 1.50

Part 1: Best Practices for the Use of Real-Time Integrated CGM Across the Spectrum of Pharmacy Care (Pharmacist Credit)

Intended Audience: Health-system, managed care, retail, and specialty pharmacists, and pharmacy technicians

Credit Available: 1.50

EXPERT FACULTY

Stephanie Redmond, PharmD, CDCES, BC-ADM Co-Founder/Co-CEO Diabetes Doctor	Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP Clinical Pharmacy Specialist and Remote Monitoring Program Coordinator Cleveland Clinic Diabetes Center
Erin Shaal, PharmD Senior Director, Pharmacy Procurement Albertsons Pharmacy	Samir Mistry, PharmD Vice President, Pharmacy External Relations Preferred-One

This activity is supported by an independent educational grant from Dexcom, Inc.

---

Expanding the Pharmacist’s Role in rtCGM Use and Education in Practice

Through this clinic scenario, learn how rtCGM systems can help patients ease concerns of hypoglycemia and improve their glucose control.

Intended Audience: This activity is intended for pharmacists.

Credit Available: Up to 0.25 contact hour(s) (0.025 CEUs).

LEARNING OBJECTIVES

Upon completion of this activity, participants will:

• Have increased knowledge regarding differences in the real-time continuous blood glucose monitoring (rtCGM) products available
• Have greater competence related to strategies for patient education related to use of rtCGM

EXPERT FACULTY

Dhiren Patel, PharmD, CDE, BC-ADM, BCACP
Clinical Pharmacy Specialist
Endocrine VA Boston Healthcare System
Adjunct Associate Professor of Pharmacy Practice
MCPHS University

 

This activity is supported by an independent educational grant from Dexcom, Inc.

---

ManagedCareCGM.com Presents: The Value of Real-Time CGM to Reduce Diabetes Costs

Intended Audience: This activity is designed to meet the educational needs of managed care pharmacy directors, clinical pharmacists, quality directors, medical directors, registered nurses, and other managed health care professionals.

Credit Available: Up to 1.0 credit hour available for nurses (ANCC), pharmacists (ACPE), and physicians (AMA PRA Category 1 Credit™)

EDUCATIONAL OBJECTIVES

• Describe the impact of real-time CGM and remote monitoring on improving outcomes and reducing costs in high-risk, high-utilizing patient populations
• Assess the clinical and economic benefits of using real-time CGM over self-monitoring of blood glucose in Medicaid and Medicare plan beneficiaries
• Review the status of ongoing plan initiatives measuring the impact of real-time CGM on health status and utilization outcomes
• Characterize the role of real-time CGM as part of an employer-driven, population health management strategy
• Identify appropriate benefit design strategies to reduce health care system burden and improve quality, clinical, and economic outcomes

EXPERT FACULTY

Daniel DeSalvo, MD Assistant Professor Pediatric Endocrinologist Baylor College of Medicine Texas Children’s Hospital

Joseph Albright, PharmD, MBA Manager, Clinical Pharmacy Services BlueCross BlueShield North Carolina

Troy Ross, MSM President & CEO Mid-America Coalition on Health Care

Jointly provided by Impact Education, LLC, and Medical Education Resources.
This activity is supported by an independent educational grant from Dexcom, Inc.

---

 

The Value of Continuous Glucose Monitoring during the COVID-19 Pandemic and New Era of Digital Healthcare

Intended Audience: This activity is designed to meet the educational needs of managed care pharmacy directors, clinical pharmacists, quality directors, medical directors, registered nurses, and other managed health care professionals.

Credit Available: Up to 1.0 credit hour available for nurses (ANCC), pharmacists (ACPE), and physicians (AMA PRA Category 1 Credit™)

EDUCATIONAL OBJECTIVES

• Describe the benefits of remote monitoring in the management of hospitalized patients with COVID-19 and dysglycemia
• Assess the value of rtCGM in improving quality of care and reducing societal health-costs in a new era of digital health
• Characterize the role of rtCGM as part of an employer-driven diabetes management strategy
• Identify appropriate benefit design strategies to reduce healthcare system burden and improve quality, clinical, and economic outcomes

EXPERT FACULTY

Daniel DeSalvo, MD Assistant Professor Pediatric Endocrinologist Baylor College of Medicine Texas Children’s Hospital

Jeffrey Dunn, PharmD, MBA (Formerly) Vice President, Clinical Strategy and Programs Industry Relations Magellan Rx Management

Troy Ross, MSM President & CEO Mid-America Coalition on Health Care

Jointly provided by Impact Education, LLC, and Medical Education Resources.
This activity is supported by an independent educational grant from Dexcom, Inc.

---

Harnessing Technology to Improve Glycemic Control: The Role of Continuous Glucose Monitoring

Intended Audience: This educational activity is intended for endocrinologists, primary care physicians, hospitalists, physician assistants, nurse practitioners, pharmacists, certified diabetes educators, managed care healthcare providers, and other healthcare providers who care for patients with diabetes. 

Credit Designation Statement: Med Learning Group designates this enduring activity for a maximum of 1.25 AMA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

Nursing Credit Information: This program would be beneficial for nurses involved in the care of patients with diabetes.
Credits: 1.25 ANCC Contact Hour(s)

EDUCATIONAL OBJECTIVES

• Analyze clinical trial data that provide the rationale for CGM
• Compare the benefits and limitations of self-monitoring blood glucose vs. continuous CGM
• Select between real-time CGM and intermittently scanned CGM based on product features and patient characteristics
• Determine optimal approaches to the interpretation and clinical use of CGM data 

FEATURES

• Whiteboard Animations
• Case-based Interactive Presentation
• Create your own personalized poster 

EXPERT FACULTY

Nicholas Argento, MD, FACE Diabetes Technology Director Maryland Endocrine and Diabetes Center

Dhiren Patel, PharmD, CDE, BC-ADM, BCACP Clinical Pharmacy Specialist Endocrine VA Boston Healthcare System Adjunct Associate Professor of Pharmacy Practice MCPHS University

To learn more, view the standalone video or access the full activity Harnessing Technology to Improve Glycemic Control: The Role of Continuous Glucose Monitoring.

This activity is supported by an independent educational grant from Dexcom, Inc.

---